Scopus Biopharma Inc
SCPS
Get informed when a big investor buys or sells
+ FollowMarket Cap$16.83K
Close$
$0.01
1375% upside
Current Fair Value
1375% upsideUndervalued by 1375% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $16,833.00 |
|---|---|
| Enterprise Value | $-345,264.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.55 |
| Beta | -2.01 |
| Outstanding Shares | 39,742,505 |
Return
| Return on Equity | 92.00% |
|---|---|
| Return on Assets | -1747.71% |
| Return on Invested Capital | 88.94% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.04 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$-0.23
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-0.23
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Scopus Biopharma Inc
1 employeesScopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics capitalizing on groundbreaking scientific and medical discoveries from leading research and academic institutions. The company’s lead drug cand...